http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89c5d5616eab9c10ef6a5a71c19aee6f
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Perez-Terzic |
| name | Carmen Perez-Terzic |
| given-name | Carmen |
| organization-name | Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Department of Medicine, Department of Molecular Pharmacology and Experimental Therapeutics, Department of Medical Genetics, and Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN 55905 Departments of Medicine and Pharmacology, Division of Cardiovascular Diseases, Mayo Clinic, Mayo Foundation Division of Cardiovascular Diseases, Departments of Medicine and Molecular Pharmacology and Experimental Therapeutics, Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN 55905; and Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University 1-8-1 Inohana, Chiba, Chuo-ku 260-8670, Japan Division of Cardiovascular Diseases, Department of Medicine, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, Minnesota; Department of Physical Medicine and Rehabilitation, Mayo Clinic College of Medicine, Rochester, Minnesota Department of Medicine, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota; Center for Regenerative Medicine, Mayo Clinic, Rochester, Minnesota; Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, Minnesota From the Division of Cardiovascular Diseases, Departments of Medicine, Molecular Pharmacology and Experimental Therapeutics (C.P.-T., A.B., A.T., M.P.); Physical Medicine and Rehabilitation (C.P.-T.); and Pediatrics and Adolescent Medicine (J.M.A.v.D.), Mayo Clinic, Mayo Foundation, Rochester, Minn, and CNRS UPR1086 (C.P.-T., A.B., A.M., M.P.), Centre de Recherches de Biochimie Macromoléculaire, Montpellier, France. Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.; Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN 55905, USA. Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, Minnesota, USA; Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Departments of Medicine, Molecular Pharmacology and Experimental Therapeutics, and Medical Genetics, Mayo Clinic, Rochester, Minnesota, USA From the Center for Regenerative Medicine (A.M.-F., T.J.N., S.R., A.E.A., A.T.), Marriott Heart Disease Research Program, Division of Cardiovascular Diseases (A.M.-F., S.R., A.E.A., A.T.), and Department of Physical Medicine and Rehabilitation (C.P.-T.), General Internal Medicine and Transplant Center (T.J.N., F.S., R.B.), Mayo Clinic, Rochester, MN; and Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada (H.-K.S., A.N.). 2CNRS UPR1086, Centre de Recherches de Biochime Macromoléculaire, Montpellier 34293, France; 4Division of Cardiovascular Diseases, Deptartment of Medicine and Deptartment of Physical Medicine and Rehabilitation, Mayo Clinic, Mayo Foundation, Rochester, MN 55905 Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Departments of Medicine, Molecular Pharmacology and Experimental Therapeutics, and Medical Genetics, Mayo Clinic, Rochester, Minnesota, USA; Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, Minnesota, USA From the Division of Cardiovascular Diseases, Departments of Medicine, Molecular Pharmacology and Experimental Therapeutics, and Medical Genetics (T.J.N., A.M.-F., S.Y., C.P.-T., A.T.); Physical Medicine and Rehabilitation (C.P.-T.); and Molecular Medicine (Y.I.), Mayo Clinic, Rochester, Minn. From the Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Departments of Medicine, Molecular Pharmacology and Experimental Therapeutics, and Medical Genetics (A.M.F., T.J.N., S.Y., S.R., A.E.A., C.P.T., A.T.), the Department of Physical Medicine and Rehabilitation (C.P.T.), and the Department of Molecular Medicine (Y.I.), Mayo Clinic, Rochester, Minn. Division of Cardiovascular Diseases, Department of Medicine, Department of Molecular Pharmacology and Experimental Therapeutics, and Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN 55905 From the Division of Cardiovascular Diseases and Department of Internal Medicine (C.P.-T., P.P.D., M.P., M.J., A.T.), the Department of Physical Medicine and Rehabilitation (C.P.-T.), and the Department of Pharmacology (A.M.G., R.B., F.G.P., A.T.), Mayo Clinic, Rochester, Minn. The current affiliation for Michel Puceat is Centre de Recherches de Biochimie Macromoleculaires, Montpellier, France. The current affiliation for Marisa Jaconi is Biology of Aging Laboratory, Geriatric Hospital, Geneva,... Department of Pharmacology, Mayo Foundation, Rochester, MN 55905, USA. 3Department of Medicine,; 4Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 Center for Regenerative Medicine, Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Department of Medicine, Molecular Pharmacology & Experimental Therapeutics, Rochester, MN 55905, USA; Department of Physical Medicine & Rehabilitation, Mayo Clinic, Rochester, MN 55905, USA Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Departments of Medicine, Molecular Pharmacology and Experimental Therapeutics, and Medical Genetics, Department of Physical Medicine and Rehabilitation, and Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota 55905 |
Incoming Links
Total number of triples: 71.